Bausch Health Companies (BHC) Prepaid Assets (2009 - 2026)
Bausch Health Companies (BHC) posted Prepaid Assets of $819.0 million for Q2 2026, down 6.29% sequentially from $874.0 million in Q1 2026, and down 9.6% YoY from $906.0 million in Q2 2025.
Bausch Health Companies (BHC) Prepaid Assets (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Prepaid Assets for 18 years, with the latest figure at $819.0 million in Q2 2026.
- Quarterly Prepaid Assets fell 9.6% year-over-year to $819.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $819.0 million (down 9.6% YoY) and the FY2025 annual result came in at $852.0 million, up 1.67% from the prior year.
- Prepaid Assets fell to $819.0 million in Q2 2026 per BHC's latest filing, from $874.0 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.1 billion in Q4 2023 and troughed at $718.0 million in Q3 2022.
- A 5-year average of $870.1 million and a median of $863.0 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets jumped 45.96% in 2023, then slipped 23.26% in 2024.
- Over 5 years, Prepaid Assets stood at $776.0 million in 2022, then surged by 40.72% to $1.1 billion in 2023, then decreased by 23.26% to $838.0 million in 2024, then increased by 1.67% to $852.0 million in 2025, then retreated by 3.87% to $819.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $819.0 million, $874.0 million, and $852.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 819.00 Mn |
| Mar 31, 2026 | 874.00 Mn |
| Dec 31, 2025 | 852.00 Mn |
| Sep 30, 2025 | 894.00 Mn |
| Jun 30, 2025 | 906.00 Mn |
| Mar 31, 2025 | 890.00 Mn |
| Dec 31, 2024 | 838.00 Mn |
| Sep 30, 2024 | 852.00 Mn |
| Jun 30, 2024 | 874.00 Mn |
| Mar 31, 2024 | 957.00 Mn |
| Dec 31, 2023 | 1.09 Bn |
| Sep 30, 2023 | 1.05 Bn |
| Jun 30, 2023 | 890.00 Mn |
| Mar 31, 2023 | 796.00 Mn |
| Dec 31, 2022 | 776.00 Mn |
| Sep 30, 2022 | 718.00 Mn |
| Jun 30, 2022 | 820.00 Mn |
| Mar 31, 2022 | 765.00 Mn |
| Dec 31, 2021 | 720.00 Mn |
| Sep 30, 2021 | 632.00 Mn |